Company Filing History:
7 out of 1,976 
3 out of 66 
1 out of 2,489 
Years Active: 1994-2011
Title: The Innovative Contributions of Keith E. Langley
Introduction
Keith E. Langley is a prominent inventor based in Newbury Park, California. He has made significant contributions to the field of biotechnology, particularly in the development of metalloproteinase inhibitors. With a total of seven patents to his name, Langley's work has had a substantial impact on pharmaceutical compositions and methods for treating various disorders.
Latest Patents
Langley's latest patents include a novel metalloproteinase inhibitor, along with its analogs and polynucleotides encoding the same. These patents disclose methods of production and pharmaceutical compositions aimed at treating disorders caused by excessive amounts of metalloproteinase. Additionally, he has developed methods for detecting metalloproteinase inhibitors, further advancing the understanding and treatment of related medical conditions.
Career Highlights
Throughout his career, Langley has worked with notable organizations such as Amgen Inc. and Children's Hospital of Los Angeles. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Langley's notable coworkers include Yves A. DeClerck and Thomas Charles Boone. Their collaborative efforts have played a crucial role in the advancement of research related to metalloproteinase inhibitors.
Conclusion
Keith E. Langley's innovative work in the field of biotechnology has led to significant advancements in the treatment of disorders related to metalloproteinase. His contributions continue to influence the pharmaceutical industry and improve patient outcomes.